A Governance Model Addressing the Challenges of Contemporary Research

Linda Downes; Rhonda Garad; Helena J. Teede; Robert J. Norman

doi:10.1055/s-0038-1667157

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2018; 36(01): 073-079
DOI: 10.1055/s-0038-1667157

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Governance Model Addressing the Challenges of Contemporary Research

Linda Downes

¹Monash Centre for Health Research and Implementation, Monash Public Health and Preventive Medicine, Monash University, and Monash Health, Melbourne, Victoria, Australia

,

Rhonda Garad

¹Monash Centre for Health Research and Implementation, Monash Public Health and Preventive Medicine, Monash University, and Monash Health, Melbourne, Victoria, Australia

,

Helena J. Teede

¹Monash Centre for Health Research and Implementation, Monash Public Health and Preventive Medicine, Monash University, and Monash Health, Melbourne, Victoria, Australia

,

Robert J. Norman

²Robinson Research Institute, University of Adelaide and Fertility SA, Adelaide, South Australia, Australia

› Institutsangaben

Abstract

In this paper, we describe the robust governance structures and processes underpinning the development of the first International Evidence-Based Guideline for the Assessment and Management Polycystic Ovary Syndrome (2018). The guideline was an outcome of the Centre of Research Excellence for Polycystic Ovary Syndrome, and an example of a transformative, strategic research initiative to impact delivery model. The governance structure supported and delivered critical ethical and regulatory outcomes, including: broad and diverse representation across health professional and consumer groups and exceeded regulatory standards; adherence to rigorous knowledge creation processes; and compliance with the standards for guidelines set by the approval body, the Australian National Health and Medical Research Council (NHMRC). Well-articulated and appropriately implemented governance structures that meet the complex nature of contemporary research and translation activities are essential to enable distributed leadership and to deliver key outcomes.

Keywords

polycystic ovary syndrome - evidence-based guidelines - governance

Volltext

Referenzen

References
1 Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2017; 102 (02) 604-612
2 Dokras A, Saini S, Gibson-Helm M, Schulkin J, Cooney L, Teede H. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril 2017; 107 (06) 1380-1386.e1
3 Teede H, Gibson-Helm M, Norman RJ, Boyle J. Polycystic ovary syndrome: perceptions and attitudes of women and primary health care physicians on features of PCOS and renaming the syndrome. J Clin Endocrinol Metab 2014; 99 (01) E107-E111
4 Balen AH, Morley LC, Misso M. , et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 2016; 22 (06) 687-708
5 Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. ; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society (AES). American Association of Clinical Endocrinologists, American College or Endocrinology and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the best practices in the evalution and treatment of polycystic ovary syndrome. Endocr Pract 2015; 21 (11) 1291-1300
6 Legro RS, Arslanian SA, Ehrmann DA. , et al; Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98 (12) 4565-4592
7 Conway G, Dewailly D, Diamanti-Kandarakis E. , et al; ESE PCOS Special Interest Group. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 2014; 171 (04) 1-29
8 Teede HJ, Misso ML, Deeks AA. , et al; Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011; 195 (06) S65-S112
9 Teede HJ, Costello MF, Dokras A. , et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110 (03)
10 Hollstein B, Matiaske W, Schnapp K-U. Networked Governance: New Research Perspectives. Cham: Springer; 2017
11 Elrod JK, Fortenberry JL. Centers of excellence in healthcare institutions: what they are and how to assemble them. BMC Health Serv Res 2017; 17 (Suppl 1): 425
12 Straus SE, Tetroe J, Graham I. Defining knowledge translation. CMAJ 2009; 181 (3–4): 165-168
13 Graham ID, Logan J, Harrison MB. , et al. Lost in knowledge translation: time for a map?. J Contin Educ Health Prof 2006; 26 (01) 13-24
14 NHMRC. A Model Framework for Consumer and Community Participation in Health and Medical Research. Canberra: National Health and Medical Research Council; 2004